Press-release for stocks related to covid

| -99.95% | O: -2.82% H: 1.64% C: -0.95%
covid-19 covid test

Empower Clinics Kai Medical Laboratory Secures COVID-19 Testing Contract For Large Gaming Event In Las Vegas
Published: 2021-12-13 (Crawled : 21:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250

| -99.95% | O: -3.43% H: 1.34% C: 0.41%
covid-19 contract covid test

Empower Clinics Signs Partnership with One of North America’s Largest Terminal Operators to Provide COVID Testing Services
Published: 2022-02-10 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250

| -99.95% | O: 3.09% H: 14.81% C: 4.19%
america partnership covid covid test services one test

Empower Clinics strikes partnership with one of North America’s largest terminal operators to provide COVID-19 testing services
Published: 2022-02-10 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250

| -99.95% | O: 3.09% H: 14.81% C: 4.19%
covid-19 america partnership covid services one test

Empower Clinics subsidiary Kai Medical approved to administer COVID-10 Vaccines in the United States
Published: 2021-10-25 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250

| -99.97% | O: 2.41% H: 0.0% C: -3.45%
covid vaccine

Empower Clinics Kai Medical Laboratory Approved to Administer Covid-19 Vaccines in the U.S.
Published: 2021-10-25 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250

| -99.97% | O: 2.41% H: 0.0% C: -3.45%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.98% | O: 0.32% H: 0.36% C: 0.22%
covid vaccine covid-19

Empower Clinics Successfully Completes Health Canada Review To Sell Covid-19 At-Home Saliva Collection Kit
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
EPWCF | $0.0001 33700.0% 250

Mining, Quarrying, and Oil and ...

| -99.94% | O: 6.05% H: 21.42% C: 14.49%
saliva covid covid-19

COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials
Published: 2022-02-11 (Crawled : 21:00) - prnewswire.com
GWHP | $0.0001 4000.0% 86K

| Email alert Add to watchlist
PMCB | $2.13 1.4% 12K

| Email alert Add to watchlist
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| Email alert Add to watchlist
covid-19 als ces trials device trial approval covid clinical trials report test

$ 169.82 Billion growth expected in Unified Communication and Collaboration Market | 46.81% YOY growth in 2021 amid COVID-19 Spread | North America to Notice Maximum Growth | Technavio
Published: 2021-05-15 (Crawled : 00:20) - prnewswire.com
EGHT | $2.37 2.16% 2.11% 580K

| Email alert Add to watchlist
EGHT 4 | $2.37 2.16% 2.11% 580K

| Email alert Add to watchlist
AVYA | $0.021 1280.95% 0

Electronic Technology

| Email alert Add to watchlist
covid collaboration communication growth

Unified Communications Market will grow at a CAGR of 24.27% amid COVID-19 Spread| SpendEdge
Published: 2021-06-14 (Crawled : 10:00) - prnewswire.com
DELL | News | $120.2 -0.36% -2.04% 5.8M

Electronic Technology

| 15.6% | O: 0.02% H: 0.21% C: -1.21%
AVYA | $0.021 1280.95% 0

Electronic Technology

| -99.01% | O: 0.36% H: 0.04% C: -3.18%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M

| -93.45% | O: 0.08% H: 0.68% C: 0.68%
GOOG | News 4 | $161.05 0.71% 0.7% 19M

| -93.59% | O: -0.02% H: 0.59% C: 0.54%
covid communication communications covid-19

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO
Published: 2021-12-09 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.16 -9.62% -10.65% 28K

Health Technology

| 3.69% | O: 9.68% H: 0.0% C: 0.0%
covid-19 partnership genetic risk patent allowance patent covid test

Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
Published: 2022-01-06 (Crawled : 10:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K

| 1183.19% | O: 19.47% H: 3.85% C: -11.85%
RLFTY | $1.4006 733.33% 100

| -91.95% | O: 2.87% H: 0.0% C: 0.0%
NRXP | $3.11 1.97% 1.93% 96K

| -37.85% | O: -3.39% H: 6.19% C: 3.92%
covid-19 treatment fda aviptadil risk covid media submission

Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K

| 1586.05% | O: 1.51% H: 3.09% C: -1.37%
RLFTY | $1.4006 733.33% 100

| -89.49% | O: -6.53% H: 3.29% C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration

Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
Published: 2022-02-16 (Crawled : 09:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K

| 1719.32% | O: -7.15% H: 7.7% C: 6.89%
covid-19 aviptadil health covid report collaboration enroll

Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19
Published: 2022-04-01 (Crawled : 08:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K

| 1974.39% | O: -9.87% H: 10.63% C: 10.63%
NRXP | $3.11 1.97% 1.93% 96K

| 27.35% | O: 0.82% H: 0.77% C: -2.02%
covid-19 covid collaboration aviptadil trial

Automotive Aftermarket Market 2023-2027: Highlights on Global Supply Chain, Covid Analysis and Latest Trends - Technavio
Published: 2023-01-24 (Crawled : 11:00) - prnewswire.com
DNZOY | $18.14 0.08% 76K

| 39.8% | O: 0.08% H: 1.07% C: 0.61%
BWA | $33.65 0.93% 0.0% 2M

Producer Manufacturing

| -24.67% | O: -1.32% H: 1.75% C: 1.0%
APTV | $71.4 1.64% 1.33% 1.9M

Producer Manufacturing

| -33.49% | O: 2.47% H: 0.0% C: -3.62%
global covid trends automotive market

Progressive Care Expands Its Corporate Services with Enhanced COVID-19 Platform Capabilities
Published: 2022-02-16 (Crawled : 12:30) - globenewswire.com
RXMD | $1.92 174.55% 2.4K

Retail Trade

| 3385.15% | O: -0.79% H: 0.0% C: -3.19%
covid-19 covid services platform

Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients
Published: 2021-11-19 (Crawled : 13:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

| -99.53% | O: 10.19% H: 4.3% C: -3.23%
covid phase 2 antiviral trial tollovir enroll

Todos Medical’s Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests
Published: 2021-11-16 (Crawled : 15:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

| -99.55% | O: -3.37% H: 11.63% C: -5.81%
covid test respiratory antibody topline

Todos Medical Reports Case Study #7 in Acute and Long COVID
Published: 2022-07-12 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M

| -98.33% | O: -1.67% H: 5.08% C: 1.69%
covid study

← Previous
1
2
3
4
5
6
7
8
9
…
126
127
Next →

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K